Sam-A Pharm. Co. Ltd (009300) — Cash Flow-to-Debt Ratio
Sam-A Pharm. Co. Ltd (009300) has a Cash Flow-to-Debt Ratio of 0.01x as of December 2025, meaning its operating cash flow of ₩162.42 Million could theoretically repay 0% of its total liabilities (₩18.93 Billion) in one year. See cash generation quality of Sam-A Pharm. Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sam-A Pharm. Co. Ltd Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Sam-A Pharm. Co. Ltd across 16 annual periods. Also explore 009300 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sam-A Pharm. Co. Ltd (2009–2025)
Year-by-year debt coverage analysis for Sam-A Pharm. Co. Ltd. For market capitalisation and broader financial context, see Sam-A Pharm. Co. Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.57x | ₩10.72 Billion | ₩18.93 Billion | ▼ -35.5% |
| 2024 | 0.88x | ₩25.25 Billion | ₩28.76 Billion | ▲ +30.4% |
| 2023 | 0.67x | ₩20.76 Billion | ₩30.84 Billion | ▼ -22.5% |
| 2022 | 0.87x | ₩19.60 Billion | ₩22.58 Billion | ▲ +15.0% |
| 2021 | 0.75x | ₩12.94 Billion | ₩17.15 Billion | ▲ +26.9% |
| 2020 | 0.59x | ₩9.41 Billion | ₩15.82 Billion | ▲ +1.8% |
| 2019 | 0.58x | ₩13.22 Billion | ₩22.63 Billion | ▼ -41.5% |
| 2018 | 1.00x | ₩12.76 Billion | ₩12.78 Billion | ▲ +132.3% |
| 2017 | 0.43x | ₩5.10 Billion | ₩11.86 Billion | ▼ -45.5% |
| 2016 | 0.79x | ₩10.53 Billion | ₩13.36 Billion | ▼ -6.4% |
| 2015 | 0.84x | ₩10.81 Billion | ₩12.83 Billion | ▼ -13.3% |
| 2014 | 0.97x | ₩11.38 Billion | ₩11.71 Billion | ▲ +62.8% |
| 2012 | 0.60x | ₩14.00 Billion | ₩23.46 Billion | ▲ +55.5% |
| 2011 | 0.38x | ₩10.47 Billion | ₩27.28 Billion | ▲ +101.5% |
| 2010 | 0.19x | ₩5.10 Billion | ₩26.76 Billion | ▲ +171.2% |
| 2009 | -0.27x | ₩-8.33 Billion | ₩31.18 Billion | — |